Quick Takeaways
- Jonathan Violin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $10,113,603.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jonathan Violin
- Location
- Chesterbrook, PA
- Summary
- The estimated net worth of Jonathan Violin is at least $10,113,603 dollars as of 23 Jan 2026. Jonathan Violin is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $10.1M. Jonathan Violin is the Director of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $14.6K.
- Signature
- /s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jonathan Violin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Viridian Therapeutics, Inc.\DE ($10,099,005).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jonathan Violin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | Chief Executive Officer, Director | $10,099,005 | 02 Feb 2023 | ||
| CBIO | GLYCOMIMETICS INC | Director | $14,598 | 23 Jun 2025 | ||
| ATXS | Astria Therapeutics, Inc. | Director | $0 | 23 Jan 2026 | ||
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | 22 May 2025 |
Insider Transactions Reported by Jonathan Violin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.